Sandbox carlos: Difference between revisions
Jump to navigation
Jump to search
Carlos Lopez (talk | contribs) No edit summary |
Carlos Lopez (talk | contribs) No edit summary |
||
| Line 8: | Line 8: | ||
::* 2. '''Outpatient treatment''' | ::* 2. '''Outpatient treatment''' | ||
::*2.1 Previously healthy and no risk factors for drug-resistant Streptococcus pneumoniae infection: | ::* 2.1 Previously healthy and no risk factors for drug-resistant Streptococcus pneumoniae infection: | ||
:::* Preferred regimen:[[Macrolides]] ([[azithromycin]], [[clarithromycin]], {{or}} [[erythromycin]]) (strong recommendation) | :::* Preferred regimen:[[Macrolides]] ([[azithromycin]], [[clarithromycin]], {{or}} [[erythromycin]]) (strong recommendation) | ||
:::* Alternative regimen: [[Doxycycline]] | :::* Alternative regimen: [[Doxycycline]] | ||
:::2.2 Preferred regimen in presence of comorbidities, such as chronic heart, lung, liver, or renal disease; diabetes mellitus; alcoholism; malignancies; asplenia; immunosuppressing conditions or use of immunosuppressing drugs; use of antimicrobials within the previous 3 months or other risks for drug resistant Streptococcus pneumoniae infection: Option A [[Fluoroquinolone]] ([[moxifloxacin]], [[gemifloxacin]], {{or}} [[levofloxacin]] Option B [[β-lactam]] {{ | :::* 2.2 Preferred regimen in presence of comorbidities, such as chronic heart, lung, liver, or renal disease; diabetes mellitus; alcoholism; malignancies; asplenia; immunosuppressing conditions or use of immunosuppressing drugs; use of antimicrobials within the previous 3 months or other risks for drug resistant Streptococcus pneumoniae infection: Option A [[Fluoroquinolone]] ([[moxifloxacin]], [[gemifloxacin]], {{or}} [[levofloxacin]] Option B [[beta-lactam]] {{and}} a [[macrolide]] | ||
:::* 2.3 Preferred regimen in regions with a high rate of infectionmacrolide-resistant S. pneumoniae: | |||
[[Fluoroquinolone]] ([[moxifloxacin]], [[gemifloxacin]], {{or}} [[levofloxacin]] and [[β-lactam]] {{and}} a [[macrolide]] | |||
::* 3. '''Inpatient non Intensive care unit treatment''' | ::* 3. '''Inpatient non Intensive care unit treatment''' | ||
:::* Preferred regimen:[[fluoroquinolone]] | :::* Preferred regimen:[[fluoroquinolone]] | ||
:::* Preferred regimen in presence of comorbidities, such as chronic heart, lung, liver, or renal disease; diabetes mellitus; alcoholism; malignancies; asplenia; immunosuppressing conditions or use of immunosuppressing drugs; use of antimicrobials within the previous 3 months or other risks for drug resistant Streptococcus pneumoniae infection: Option A [[Fluoroquinolone]] ([[moxifloxacin]], [[gemifloxacin]], {{or}} [[levofloxacin]] Option B [[β-lactam]] {{ | :::* Preferred regimen in presence of comorbidities, such as chronic heart, lung, liver, or renal disease; diabetes mellitus; alcoholism; malignancies; asplenia; immunosuppressing conditions or use of immunosuppressing drugs; use of antimicrobials within the previous 3 months or other risks for drug resistant Streptococcus pneumoniae infection: Option A [[Fluoroquinolone]] ([[moxifloxacin]], [[gemifloxacin]], {{or}} [[levofloxacin]] Option B [[β-lactam]] {{and}} a [[macrolide]] | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
Revision as of 14:14, 15 July 2015
- Mycoplasma pneumoniae
Return to Top
-
- 1. Community-acquired pneumonia
- Preferred regimen: Macrolide OR Tetracycline
- Alternative regimen: Fluoroquinolone
- 2. Outpatient treatment
- 2.1 Previously healthy and no risk factors for drug-resistant Streptococcus pneumoniae infection:
- Preferred regimen:Macrolides (azithromycin, clarithromycin, OR erythromycin) (strong recommendation)
- Alternative regimen: Doxycycline
- 2.2 Preferred regimen in presence of comorbidities, such as chronic heart, lung, liver, or renal disease; diabetes mellitus; alcoholism; malignancies; asplenia; immunosuppressing conditions or use of immunosuppressing drugs; use of antimicrobials within the previous 3 months or other risks for drug resistant Streptococcus pneumoniae infection: Option A Fluoroquinolone (moxifloxacin, gemifloxacin, OR levofloxacin Option B beta-lactam AND a macrolide
- 2.3 Preferred regimen in regions with a high rate of infectionmacrolide-resistant S. pneumoniae:
Fluoroquinolone (moxifloxacin, gemifloxacin, OR levofloxacin and β-lactam AND a macrolide
- 3. Inpatient non Intensive care unit treatment
- Preferred regimen:fluoroquinolone
- Preferred regimen in presence of comorbidities, such as chronic heart, lung, liver, or renal disease; diabetes mellitus; alcoholism; malignancies; asplenia; immunosuppressing conditions or use of immunosuppressing drugs; use of antimicrobials within the previous 3 months or other risks for drug resistant Streptococcus pneumoniae infection: Option A Fluoroquinolone (moxifloxacin, gemifloxacin, OR levofloxacin Option B β-lactam AND a macrolide
References
- ↑ Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC; et al. (2007). "Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults". Clin Infect Dis. 44 Suppl 2: S27–72. doi:10.1086/511159. PMID 17278083.
- ↑ Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.